PHARMACEUTICAL PREPARATIONS T CELL

Brand Owner (click to sort) Address Description
GAMMABODY Lava Therapeutics N.V. YALELAAN 60 NL-3584 CM UTRECHT Netherlands Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment or diagnosis of cancer, autoimmune diseases and immunological disorders;Antibodies for scientific and research use; proteins, enzymes, and chemical and biochemical preparations and substances for use in the manufacture of medicines;Providing health information about the treatment or diagnosis of cancer, autoimmune diseases and immunological disorders via a website;Bio-technology and scientific services, namely, scientific and medical research relating to bio-technology and science, namely, antibodies, proteins and enzymes; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, scientific and medical research in the fields of antibodies, protein and enzyme evolving services; biochemistry research services, namely, scientific and medical research in the fields of antibodies, protein and enzyme cataloging and library services;
PROCAR Harpoon Therapeutics, Inc. 4000 Shoreline Court, Suite 250 South San Francisco CA 94080 Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer;PRO CAR;Pharmaceutical research and development;
PROTRITAC Harpoon Therapeutics, Inc. 4000 Shoreline Court, Suite 250 South San Francisco CA 94080 Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer;Pharmaceutical research and development;
PROTRITAC Harpoon Therapeutics, Inc. 4000 Shoreline Court, Suite 250 South San Francisco CA 94080 Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer;Pharmaceutical research and development;
TRITAC Harpoon Therapeutics, Inc. 4000 Shoreline Court, Suite 250 South San Francisco CA 94080 Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors;Pharmaceutical research and development;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides medicinal or pharmaceutical compositions and preparations for administration, which are useful as cytoprotective agents and a remedy for neurotrauma, comprising ginseng, its extract, ginseng components, metabolites thereof or salts thereof (for example, red ginseng powder or components thereof). More particularly, the present invention provides medicinal or pharmaceutical compositions for inhibiting apoptosis or apoptosis-like cell death, medicinal or pharmaceutical compositions for promoting the expression of a cell death-suppressing gene product Bcl-xL, or preparations for oral or intravenous administration, comprising ginseng, its extracts, ginseng components, metabolites thereof or salts thereof preferably at low concentrations. These medicinal or pharmaceutical compositions and/or preparations for administration are characterized by containing, as the active ingredient(s), ginseng, its extracts, ginseng components, metabolites thereof or salts thereof at low concentrations. These drugs are useful for therapy, prevention or treatment of brain and nervous diseases, heart diseases, etc.